Skip to content
pixantrone

Structure via PubChem · Public domain (PubChem)

EntityQ7199690· pop 10· linked from 276 articles

pixantrone

Sign in to save

Also known as BBR-2778, PIX, 6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione

Pixantrone (rINN; trade name Pixuvri) is an experimental antineoplastic (anti-cancer) drug, an analogue of mitoxantrone with fewer toxic effects on cardiac tissue. It acts as a topoisomerase II poison and intercalating agent. The code name BBR 2778 refers to pixantrone dimaleate, the actual substance commonly used in clinical trials.

Chemical data

Formula
C17H19N5O2
Molecular weight
325.4 g/mol
IUPAC name
6,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione
SMILES
C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN
InChIKey
PEZPMAYDXJQYRV-UHFFFAOYSA-N
XLogP
1
Polar surface area
123 Ų
H-bond donors
4
H-bond acceptors
7
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2012
Indications
neoplasm, lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia

via ChEMBL · EBI

Wikidata facts

Mass
325.153875
Has use
medication
Show 3 more facts
chemical formula
C₁₇H₁₉N₅O₂
Commons category
Pixantrone
canonical SMILES
C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN
Sources (3)

via Wikidata · CC0

~8 min read

Encyclopedic overview

9 sections
Contents
  • History
  • Clinical trials
  • Administration
  • Society and culture
  • Legal status
  • US Food and Drug Administration
  • European Medicines Agency
  • Research
  • References

Pixantrone (rINN; trade name Pixuvri) is an experimental antineoplastic (anti-cancer) drug, an analogue of mitoxantrone with fewer toxic effects on cardiac tissue. It acts as a topoisomerase II poison and intercalating agent. The code name BBR 2778 refers to pixantrone dimaleate, the actual substance commonly used in clinical trials.

==History== Anthracyclines are important chemotherapy agents. However, their use is associated with irreversible and cumulative heart damage. Investigators have attempted to design related drugs that maintain the biological activity, but do not possess the cardiotoxicity of the anthracyclines. Pixantrone was developed to reduce heart damage related to treatment while retaining efficacy.

Excerpted from Wikipedia’s “pixantrone” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0